458
Participants
Start Date
May 31, 2004
Primary Completion Date
May 31, 2008
Study Completion Date
January 31, 2012
laboratory biomarker analysis
Biomarkers (C-telopeptide, osteocalcin and skeletal alkaline phosphatase) will be assessed in serum.
Dual energy X-ray absorptiometry (DEXA)
Mone mineral density measurements of L2-L4 and hip will be performed using DEXA.
Spine X-ray
Thoracic and lumbar X-ray (T4-L4, lateral projection) will be performed.
Instituto Nacional de Enfermedades Neoplasicas, Lima
Institute of Oncology at Prince of Wales Hospital, Randwick
Regionalspital, Thun
Royal Brisbane and Women's Hospital, Brisbane
Groote Schuur Hospital, Cape Town
European Institute of Oncology, Milan
Ospedali Riuniti di Bergamo, Bergamo
Hospital Ruber Internacional, Madrid
Institut Bergonie, Bordeaux
Centro di Riferimento Oncologico - Aviano, Aviano
Dunedin Hospital, Dunedin
Kantonspital Aarau, Aarau
Inselspital Bern, Bern
Centre Hospitalier Universitaire Vaudois, Lausanne
Ospedale Beata Vergine, Mendrisio
Kantonsspital - St. Gallen, Sankt Gallen
ETOP IBCSG Partners Foundation
NETWORK